The effects of antihypertensive agents on atherosclerosis-related parameters of human aorta intimal cells

Cardiology

Volumn 89, Issue 2, 1998, Pages 111-118

  Orekhov, Alexander N ^a   Tertov, Vladimir V ^a   Pivovarova, Elena M ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Amlodipine; Antiatherogenic effect; Antiatherosclerotic effect; Perindoprilat; Propranolol; Verapamil

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; PERINDOPRILAT; PROPRANOLOL; PROTEIN; VERAPAMIL;

AORTA; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SMOOTH MUSCLE FIBER;

ADULT; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; AORTA; ARTERIOSCLEROSIS; CELL DIVISION; CELLS, CULTURED; CHOLESTEROL; DNA; HUMANS; INDOLES; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PROPRANOLOL; PROTEIN BIOSYNTHESIS; TUNICA INTIMA; VERAPAMIL;

EID: 0031891822     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000006765     Document Type: Article

References (25)

1. Kober G, Schneider W, Kaltenbach M: Can the progression of coronary sclerosis be influenced by calcium antagonists? J Cardiovasc Pharmacol 1989;13:S2-S6.
2. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Deckers JW - on behalf of the INTACT group investigators: Retardation of angiographie progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). Lancet 1990;335:1109-1113.
3. Waters D, Lesperance J, Francetich M, Causey D, Theroux P, Chiang YK, Hudon G, Lemarbre L, Reitman M, Joyal M, Gosselin G, Dyrda I, Macer J, Havel RJ: A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 1999;82:1940-1953.
4. Borhani NO, Mercuri M, Borhani PA, Buckalew VM Jr, Canossa-Terris M, Carr AA, Kappagoda T, Rocco MW, Schnaper HW, Sowers JR, Bond MG: Final outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS) - a randomized controlled trial. JAMA 1996;276:785-791.
5. Ambrosioni E, Bacchelli S, Degli Esposti D, Borghi C: ACE Inhibitors and experimental atherosclerosis. Clin Exp Hypertens 1993;15: 157-172.
6. The Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group: Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR Study: A multicenter, randomized, double-blind placebo-controlled trial. Circulation 1992;86:100-110.
7. Loaldi A, Polese A, Montorsi P, De Cesare N, Fabbiocchi F, Ravagnani P, Guazzi MD: Comparison of nifedipine, propranolol and isosor-bide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris. Am J Cardiol 1989;64:433-439.
8. Orekhov AN, Andrianova IV, Rekhter MD, Tertov VV, Andreeva ER, Ragimov SE, Mironov AA: Beta-blockers: Propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverine. Atherosclerosis 1992;95:77-85.
9. Orekhov AN, Baldenkov GN, Tertov VV, Li Hwa Ryong, Kozlov SG, Lyakishev AA, Tkachuk VA, Ruda MYA, Smirnov VN: Cardiovascular drugs and atherosclerosis: Effects of calcium antagonists, beta-blockers and nitrates on artherosclerotic characteristics of human aortic cells. J Cardiovasc Pharmacol 1988; 12: S66-S68.
10. Orekhov AN, Tertov VV, Kudryashov SA, Khashimov KhA, Smirnov VN: Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents. Atherosclerosis 1986;60:101-110.
11. Andreeva ER, Rekhter MD, Romanov YuA, Antova GM, Antonov AS, Mironov AA, Orekhov AN: Stellate cells of aortic intima. II. Arborization of intimai cells in culture. Tissue Cell 1992;24:697-704.
12. Hara A, Radin NS: Lipid extraction of tissue with low-toxicity solvent. Anal Biochem 1978; 90:420-426.
13. Tertov W, Orekhov AN, Kudryashov SA, Klibanov AL, Ivanov NN, Torchilin VP, Smirnov VN: Cyclic nucleotides and atherosclerosis: Studies in primary culture of human aortic cells. Exp Mol Pathol 1987;47:377-389.
14. Orekhov AN, Tertov VV, Kudryashov SA, Smirnov VN: Triggerlike stimulation of cholesterol accumulation and DNA and extracellular matrix synthesis induced by atherogenic serum or low density lipoprotein in cultured cells. Circ Res 1990;66:311-320.
15. Dixon WJ, Brown MB: Biomedical Computer Programs. P-Series. Berkeley, University of California Press, 1977, pp 185-198.
16. Doggrell SA: The membrane stabilizing and beta-1-adrenoceptor blocking activity of (+)- and (-)-propranolol on the rat left atria. Gen Pharmacol 1990;21:677-680.
17. Andersson RGG, Arngvist HJ, Lundholm L: Influence of cyclic nucleotides on protein synthesis in vascular smooth muscle. Experientia 1976;32:601-602.
18. Hajjar DP, Weksler BB, Falcone DJ, Hefton JM, Tack-Goldman K, Minick CR: Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells. J Clin Invest 1982;70:479-488.
19. Stout RW: Cyclic AMP: A potent inhibitor of DNA synthesis in cultured endothelial and smooth muscle cells. Diabetologia 1982;22:51-55.
20. Parmley WW: Vascular protection from atherosclerosis: Potential of calcium antagonists. Am J Cardiol 1990;66:161-221.
21. Fleckenstein A, Frey M, Thimm F, Fleckenstein-Grun G: Excessive mural calcium overload - a predominant causal factor in the development of stenosing coronary plaques in humans. Cardiovasc Drugs Ther 1990;4:1005-1013.
22. Kaplan JR, MAnuck SB, Adams MR, Clarkson TB: The effects of beta-adrenergic blocking agents on atherosclerosis and its complications. Eur Heart J 1987;8:928-944.
23. Meredith PA, Elliot HL: Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet 1992;22:22-31.
24. Ablad B, Bjorkman JA, Gustafsson D, Hansson G, Ostlund-Lindgvist AM, Pettersson K: The role of sympathetic activity in atherogenesis: Effects of B-blockade. Am Heart J 1988;116: 322-327.
25. Frishman WH: Beta-adrenergic blockers as cardioprotective agents. Am J Cardiol 1992;70: 21-61.